STAGE III SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Clinical trials for STAGE III SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy boost may slow rare sarcomas
Disease control Recruiting nowThis phase 3 trial tests whether adding an immunotherapy drug (pembrolizumab) to standard chemotherapy (doxorubicin) helps people with advanced or spreading sarcomas live longer without their cancer getting worse. About 365 adults with specific sarcoma types will be randomly assi…
Matched conditions: STAGE III SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo aims to halt sarcoma growth in advanced cancers
Disease control Recruiting nowThis study tests whether adding abemaciclib (a drug that blocks cancer cell growth) to gemcitabine chemotherapy is safe and works better than standard treatment for people with advanced soft tissue sarcomas, including leiomyosarcoma and liposarcoma. The trial has two phases: firs…
Matched conditions: STAGE III SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:05 UTC